These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 8399624)
1. Prevalence of symptomatic arterial disease and risk factors for its development in patients on continuous ambulatory peritoneal dialysis. Webb AT; Brown EA Perit Dial Int; 1993; 13 Suppl 2():S406-8. PubMed ID: 8399624 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of intermittent claudication and risk factors for its development in patients on renal replacement therapy. Webb AT; Franks PJ; Reaveley DA; Greenhalgh RM; Brown EA Eur J Vasc Surg; 1993 Sep; 7(5):523-7. PubMed ID: 8405496 [TBL] [Abstract][Full Text] [Related]
3. The cardiovascular risk factor profiles among end-stage renal failure patients treated with continuous ambulatory peritoneal dialysis and intermittent hemodialysis. Zamiah SAKS; Draman CR; Seman MR; Safhan AF; Rozalina R; Nik Ruzni NI Saudi J Kidney Dis Transpl; 2018; 29(1):114-119. PubMed ID: 29456216 [TBL] [Abstract][Full Text] [Related]
4. Is atherosclerosis accelerated by CAPD? Kawaguchi Y; Kubo H; Yamamoto H; Nakayama M; Yokoyama K; Shigematsu T; Sakai O Perit Dial Int; 1996; 16 Suppl 1():S223-30. PubMed ID: 8728197 [TBL] [Abstract][Full Text] [Related]
5. Influence of variation at the apolipoprotein E locus on lipid and lipoprotein levels in CAPD patients. Eggertsen G; Heimbürger O; Stenvinkel P; Berglund L Nephrol Dial Transplant; 1997 Jan; 12(1):141-4. PubMed ID: 9027789 [TBL] [Abstract][Full Text] [Related]
6. Smoking, blood pressure and serum albumin are major determinants of carotid atherosclerosis in dialysis patients. CREED Investigators. Cardiovascular Risk Extended Evaluation in Dialysis patients. Malatino LS; Benedetto FA; Mallamaci F; Tripepi G; Zoccali C; Parlongo S; Cutrupi S; Marino C; Panuccio V; Garozzo M; Candela V; Bellanuova I; Cataliotti A; Rapisarda F; Fatuzzo P; Bonanno G; Seminara G; Stancanelli B; Tassone F; Labate C J Nephrol; 1999; 12(4):256-60. PubMed ID: 10493569 [TBL] [Abstract][Full Text] [Related]
7. Lipids, lipoproteins and apolipoproteins A-I and B and apolipoprotein losses in continuous ambulatory peritoneal dialysis. Steele J; Billington T; Janus E; Moran J Atherosclerosis; 1989 Sep; 79(1):47-50. PubMed ID: 2803346 [TBL] [Abstract][Full Text] [Related]
8. Atherosclerosis risk is higher in continuous ambulatory peritoneal dialysis patients than in hemodialysis patients. Ozdemir FN; Güz G; Sezer S; Arat Z; Turan M; Haberal M Artif Organs; 2001 Jun; 25(6):448-52. PubMed ID: 11453874 [TBL] [Abstract][Full Text] [Related]
9. Symptomatic exacerbation of peripheral vascular disease with chronic ambulatory peritoneal dialysis. Brown PM; Johnston KW; Fenton SS; Cattran DC Clin Nephrol; 1981 Nov; 16(5):258-61. PubMed ID: 7307353 [TBL] [Abstract][Full Text] [Related]
10. Impact of dialysis duration and glucose absorption on nutritional indices in stable continuous ambulatory peritoneal dialysis patients. Pajek J; Gucek A; Kveder R; Bucar-Pajek M; Kaplan-Pavlovcic S; Bren AF J Ren Nutr; 2008 Nov; 18(6):503-8. PubMed ID: 18940653 [TBL] [Abstract][Full Text] [Related]
12. Prevalence and risk factors for peripheral artery disease among patients on maintenance peritoneal dialysis. Tian SL; Murphy M; Han QF; Lu XH; Wang T Blood Purif; 2010; 30(1):50-5. PubMed ID: 20616544 [TBL] [Abstract][Full Text] [Related]
13. Positive correlation of CRP and fibrinogen levels as cardiovascular risk factors in early stage of continuous ambulatory peritoneal dialysis patients. Tekin IO; Pocan B; Borazan A; Ucar E; Kuvandik G; Ilikhan S; Demircan N; Ozer C; Kadayifci S Ren Fail; 2008; 30(2):219-25. PubMed ID: 18300125 [TBL] [Abstract][Full Text] [Related]